4.7 Article

A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 104, Issue 5, Pages 985-989

Publisher

CELL PRESS
DOI: 10.1016/j.ajhg.2019.03.018

Keywords

-

Funding

  1. Wellcome [WT206194]
  2. Wellcome Trust Senior Investigator award [WT098395/Z/12/Z]
  3. NIHR
  4. Wellcome Trust
  5. Royal Society [105636/Z/14/Z]
  6. Wellcome Trust Intermediate Clinical Fellowship [105914/Z/14/Z]
  7. Research Foundation-Flanders (FWO)
  8. VUB Research Council
  9. Stichting Diabetes Onderzoek Nederland
  10. [50565]
  11. Wellcome Trust [105914/Z/14/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

We report a recurrent CNOT1 de novo missense mutation, GenBank: NM_016284.4; c.1603C>T (p.Arg535Cys), resulting in a syndrome of pancreatic agenesis and abnormal forebrain development in three individuals and a similar phenotype in mice. CNOT1 is a transcriptional repressor that has been suggested as being critical for maintaining embryonic stem cells in a pluripotent state. These findings suggest that CNOT1 plays a critical role in pancreatic and neurological development and describe a novel genetic syndrome of pancreatic agenesis and holoprosencephaly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available